SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-17-002349
Filing Date
2017-05-12
Accepted
2017-05-12 16:31:25
Documents
54
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q s106083_10q.htm 10-Q 288774
2 EXHIBIT 31.01 s106083_ex31-01.htm EX-31.01 9811
3 EXHIBIT 31.02 s106083_ex31-02.htm EX-31.02 10126
4 EXHIBIT 32.01 s106083_ex32-01.htm EX-32.01 5405
  Complete submission text file 0001615774-17-002349.txt   2642765

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE tnxp-20170331.xml EX-101.INS 430533
6 XBRL SCHEMA FILE tnxp-20170331.xsd EX-101.SCH 28861
7 XBRL CALCULATION FILE tnxp-20170331_cal.xml EX-101.CAL 37550
8 XBRL DEFINITION FILE tnxp-20170331_def.xml EX-101.DEF 148156
9 XBRL LABEL FILE tnxp-20170331_lab.xml EX-101.LAB 263951
10 XBRL PRESENTATION FILE tnxp-20170331_pre.xml EX-101.PRE 221666
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36019 | Film No.: 17839116
SIC: 2834 Pharmaceutical Preparations